Study of an experimental drug for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This study tests a new pill called HLX97 for people with advanced breast, prostate, or lung cancer that has not responded to standard treatments. The goal is to find the safest dose and see if it can help slow or shrink the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have advanced breast, prostate, or lung cancer that has stopped responding to treatment or has no standard treatment available
- You are generally able to care for yourself (up and about)
- Your cancer is of a type called HR-positive for breast cancer, or castration-resistant for prostate cancer, or non-small cell lung cancer
- You have not had another cancer in the last 3 years, except for certain early-stage curable types
- You do not have uncontrolled fluid buildup in the lungs, belly, or around the heart that needs draining every month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug (HLX48) in people with advanced or metastatic solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe and how well it works.
This early-phase study tests a new drug called HLX37 for people with advanced solid tumors that haven't responded to standard treatments. The goal is to see if it is safe and how it works in the body.
This trial tests a new experimental drug called HLX316 in people with advanced or metastatic (spread) solid cancers that have not responded to standard treatments. The drug is designed to help your immune system fight cancer cells.
This trial tests a new drug (HLX43) for people with a certain type of advanced breast cancer that has stopped responding to hormone therapy. The goal is to see if the drug can shrink tumors or slow the cancer's growth.
This trial tests a new drug called HLX43 for people with advanced or metastatic solid tumors that have not responded to standard treatments. It aims to find safe dosing and understand how the drug works in the body.
This trial tests a new drug called HLX42 for people with advanced solid tumors (including a type of lung cancer called NSCLC) who have no good treatment options left. The goal is to see if it's safe and if it can help shrink tumors.
Hear when a new Advanced/Metastatic Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.